GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 18, 2024 |
PDB ID ▼ | UniProt ID | Title | Descriptor |
---|---|---|---|
7M71 | P0DTC2 | SARS-CoV-2 Spike:5A6 Fab complex I focused refinement | |
7M71 | 7M71 | SARS-CoV-2 Spike:5A6 Fab complex I focused refinement | |
7M6S | O93430 | Full length alpha1 Glycine receptor in presence of 1mM Glycine and 32uM Tetrahydrocannabinol State 3 | |
7M6R | O93430 | Full length alpha1 Glycine receptor in presence of 1mM Glycine and 32uM Tetrahydrocannabinol State 2 | |
7M6Q | O93430 | Full length alpha1 Glycine receptor in presence of 1mM Glycine and 32uM Tetrahydrocannabinol State 1 | |
7M6P | O93430 | Full length alpha1 Glycine receptor in presence of 1mM Glycine | |
7M6O | O93430 | Full length alpha1 Glycine receptor in presence of 0.1mM Glycine and 32uM Tetrahydrocannabinol | |
7M6N | O93430 | Full length alpha1 Glycine receptor in presence of 0.1mM Glycine | |
7M6M | O93430 | Full length alpha1 Glycine receptor in presence of 32uM Tetrahydrocannabinol | |
7M6I | P0DTC2 | Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG1-24 | |
7M6I | 7M6I | Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG1-24 | |
7M6H | P0DTC2 | Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG7-20 | |
7M6H | 7M6H | Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG7-20 | |
7M6G | P0DTC2 | Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG7-15 | |
7M6G | 7M6G | Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG7-15 | |
7M6F | P0DTC2 | Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG1-22 | |
7M6F | 7M6F | Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG1-22 | |
7M6E | P0DTC2 | Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG10-19 | |
7M6E | 7M6E | Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG10-19 | |
7M6D | 7M6D | Structure of the SARS-CoV-2 RBD in complex with neutralizing antibodies BG4-25 and CR3022 | |
7M6D | P0DTC2 | Structure of the SARS-CoV-2 RBD in complex with neutralizing antibodies BG4-25 and CR3022 | |
7M5Y | Q9NQ11 | human ATP13A2 in the outward-facing E2 state bound to spermine and magnesium fluoride | |
7M5X | Q9NQ11 | Human ATP13A2 in the outward-facing E2 state bound to spermine and beryllium fluoride | |
7M5V | Q9NQ11 | human ATP13A2 in the AMPPNP-bound occluded state | |
7M5E | A0A140AYW5 | MERS-CoV S bound to the broadly neutralizing B6 Fab fragment (C3 refinement) | |
7M42 | 7M42 | Complex of SARS-CoV-2 receptor binding domain with the Fab fragments of neutralizing antibodies REGN10985 and REGN10989 | |
7M42 | P0DTC2 | Complex of SARS-CoV-2 receptor binding domain with the Fab fragments of neutralizing antibodies REGN10985 and REGN10989 | |
7M3J | P41180 | Asymmetric Activation of the Calcium Sensing Receptor Homodimer | |
7M3I | 7M3I | Structure of SARS-CoV-2 spike protein receptor binding domain in complex with a neutralizing antibody, CV2-75 Fab | |
7M3I | P0DTC2 | Structure of SARS-CoV-2 spike protein receptor binding domain in complex with a neutralizing antibody, CV2-75 Fab | |
7M3G | P41180 | Asymmetric Activation of the Calcium Sensing Receptor Homodimer | |
7M3G | 7M3G | Asymmetric Activation of the Calcium Sensing Receptor Homodimer | |
7M3F | P41180 | Asymmetric Activation of the Calcium Sensing Receptor Homodimer | |
7M3E | P41180 | Asymmetric Activation of the Calcium Sensing Receptor Homodimer | |
7M30 | P16832 | Cryo-EM structure of the HCMV pentamer bound by antibodies 1-103, 1-32 and 2-25 | |
7M30 | C8BLJ3 | Cryo-EM structure of the HCMV pentamer bound by antibodies 1-103, 1-32 and 2-25 | |
7M30 | A0A0G2TB82 | Cryo-EM structure of the HCMV pentamer bound by antibodies 1-103, 1-32 and 2-25 | |
7M30 | Q38M21 | Cryo-EM structure of the HCMV pentamer bound by antibodies 1-103, 1-32 and 2-25 | |
7M30 | 7M30 | Cryo-EM structure of the HCMV pentamer bound by antibodies 1-103, 1-32 and 2-25 | |
7M2D | Q05320 | Crystal Structure of Ebola zaire Envelope glycoprotein GP in complex with compound ARN0074953 | |
7M22 | C8BLJ3 | Cryo-EM structure of the HCMV pentamer bound by human neuropilin 2 | |
7M22 | A0A0G2TB82 | Cryo-EM structure of the HCMV pentamer bound by human neuropilin 2 | |
7M22 | Q38M21 | Cryo-EM structure of the HCMV pentamer bound by human neuropilin 2 | |
7M22 | O60462 | Cryo-EM structure of the HCMV pentamer bound by human neuropilin 2 | |
7M1Q | P78363 | Human ABCA4 structure in complex with N-ret-PE | |
7M1P | P78363 | Human ABCA4 structure in the unbound state | |
7M0I | C6F474 | Crystal structure of a human metapneumovirus subtype B2 trimeric fusion protein | |
7LZI | Q8GXJ4 | Structure of the glutamate receptor-like channel AtGLR3.4 | |
7LZH | Q8GXJ4 | Structure of the glutamate receptor-like channel AtGLR3.4 | |
7LZE | Q6WBA7 | Cryo-EM Structure of disulfide stabilized HMPV F v4-B |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024